Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Aphria Inc. APHA

Aphria, which is headquartered in Ontario, produces and sells medicinal and recreational cannabis. The company operates through retail and wholesale channels in Canada and internationally. Aphria is a main distributor of medical cannabis to Germany and has operations in over 10 countries outside of Canada. However, it does not have exposure to the U.S. CBD or THC markets due to the constraints of federal prohibition. It has some U.S. exposure through the acquisition of SweetWater, a craft brewer


NDAQ:APHA - Post by User

Bullboard Posts
Post by N00bInvesT0Ron Apr 17, 2019 4:26pm
209 Views
Post# 29640627

Reminder for the longs

Reminder for the longs
1- Ignore button for non constructive posts is your best friend

2-  Aphria expects 500M (115 000 Kg) by the end of fiscal year 2019 (Excluding CC Pharma)

3- Aphria expects 1B (255 000 Kg by the end of fiscal year 2020 (Excluding CC Pharma)

Link for fact #1 and #2 : https://www.fool.com/earnings/call-transcripts/2019/04/15/aphria-inc-apha-q3-2019-earnings-call-transcript.aspx

4- CC Pharma registered 262 M euros revenues for fiscal year 2018 which means 395M canadian

Link for fact #4 :  https://aphria.ca/blog/aphria-completes-acquisition-of-cc-pharma-leading-german-pharmaceutical-and-medical-cannabis-distributor/

Assuming CC pharma keeps the same performance:
Revenues fiscal year 2019: 500M + 395M = 895M
Revenues fiscal year 2020:  1B + 395M = 1,395B$

5- The so called leader of the sector Canopy Growth Corp is projecting 1B$ revenues for fiscal year 2020

Link for fact #5 : https://www.ctvnews.ca/business/canopy-growth-ceo-expects-to-hit-1b-in-revenue-for-fiscal-year-2020-1.4381880

6-  Weed is worth 7 Aphria in terms of market cap yet they can only do 1B$ revenues for fiscal yer 2020

Yup thats the magic of DD, you're welcome





Bullboard Posts